Ectopic expression of inactive forms of yeast DNA topoisomerase II confers resistance to the anti-tumour drug, etoposide
- 1 May 1996
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 73 (10) , 1201-1209
- https://doi.org/10.1038/bjc.1996.231
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- DNA topoisomerase II mutations and resistance to anti‐tumor drugsBioEssays, 1995
- Phosphorylation of the C-terminal Domain of Yeast Topoisomerase II by Casein Kinase II Affects DNA-Protein InteractionJournal of Molecular Biology, 1994
- A Novel Mutant Topoisomerase II.alpha. Present in VP-16-Resistant Human Melanoma Cell Lines Has a Deletion of Alanine 429Biochemistry, 1994
- SIR3 and SIR4 proteins are required for the positioning and integrity of yeast telomeresCell, 1993
- THE ROLE OF DNA TOPOISOMERASES II IN DRUG RESISTANCEBritish Journal of Haematology, 1993
- When good enzymes go bad: Conversion of topoisomerase II to a cellular toxin by antineoplastic drugsChemical Research in Toxicology, 1993
- Altered Phosphorylation, Biosynthesis and Degradation of the 170 kDa Isoform of Topoisomerase II in Amsacrine-Resistant Human Leukemia CellsBiochemical and Biophysical Research Communications, 1993
- Localization of RAP1 and topoisomerase II in nuclei and meiotic chromosomes of yeastThe Journal of cell biology, 1992
- Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase IIJournal of Molecular Biology, 1992
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989